Back to Search Start Over

Pulmonary health effects of wintertime particulate matter from California and China following repeated exposure and cessation.

Authors :
Yuan W
Velasquez SC
Wu CW
Fulgar CC
Zhang Q
Young DE
Bein KJ
Vogel CFA
Li W
Cui L
Wei H
Pinkerton KE
Source :
Toxicology letters [Toxicol Lett] 2022 Jan 01; Vol. 354, pp. 33-43. Date of Electronic Publication: 2021 Oct 29.
Publication Year :
2022

Abstract

Epidemiological studies show strong associations between fine particulate matter (PM <subscript>2.5</subscript> ) air pollution and adverse pulmonary effects. In the present study, wintertime PM <subscript>2.5</subscript> samples were collected from three geographically similar regions-Sacramento, California, USA; Jinan, Shandong, China; and Taiyuan, Shanxi, China-and extracted to form PM <subscript>CA</subscript> , PM <subscript>SD</subscript> , and PM <subscript>SX</subscript> , respectively, for comparison in a BALB/c mouse model. Each of four groups was oropharyngeally administered Milli-Q water vehicle control (50 μL) or one type of PM extract (20 μg/50 μL) five times over two weeks. Mice were necropsied on post-exposure days 1, 2, and 4 and examined using bronchoalveolar lavage (BAL), histopathology, and assessments of cytokine/chemokine mRNA and protein expression. Chemical analysis demonstrated all three extracts contained black carbon, but PM <subscript>SX</subscript> contained more sulfates and polycyclic aromatic hydrocarbons (PAHs) associated with significantly greater neutrophil numbers and greater alveolar/bronchiolar inflammation on post-exposure days 1 and 4. On day 4, PM <subscript>SX</subscript> -exposed mice also exhibited significant increases in interleukin-1 beta, tumor necrosis factor-alpha, and chemokine C-X-C motif ligands-3 and -5 mRNA, and monocyte chemoattractant protein-1 protein. These combined findings suggest greater sulfate and PAH content contributed to a more intense and progressive inflammatory response with repeated PM <subscript>SX</subscript> compared to PM <subscript>CA</subscript> or PM <subscript>SD</subscript> exposure.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1879-3169
Volume :
354
Database :
MEDLINE
Journal :
Toxicology letters
Publication Type :
Academic Journal
Accession number :
34757175
Full Text :
https://doi.org/10.1016/j.toxlet.2021.10.014